©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Feb 7, 2019; 25(5): 539-551
Published online Feb 7, 2019. doi: 10.3748/wjg.v25.i5.539
Published online Feb 7, 2019. doi: 10.3748/wjg.v25.i5.539
Contribution of ghrelin to functional gastrointestinal disorders’ pathogenesis
Tilemachos Koutouratsas, Maria Gazouli, Department of Basic Medical Science, Laboratory of Biology, School of Medicine, University of Athens, Athens 11527, Greece
Theodora Kalli, Gastroenterology Department, Larnaca General Hospital, Larnaca 6301, Cyprus
Georgios Karamanolis, Gastroenterology Unit, 2nd Department of Surgery, “Aretaieio” University Hospital, School of Medicine, University of Athens, Athens 11527, Greece
Author contributions: All authors equally contributed to this review with conception and design of literature review and analysis, drafting and critical revision and editing, and approval of the final version.
Conflict-of-interest statement: No conflicts of interest.
Corresponding author: Maria Gazouli, PhD, Associate Professor, Laboratory of Biology, Medical School, National and Kapodistrian University of Athens, Michalakopoulou 176, Athens 11527, Greece. mgazouli@med.uoa.gr
Telephone: +30-210-7462231
Received: November 21, 2018
Peer-review started: November 22, 2018
First decision: December 12, 2018
Revised: December 20, 2018
Accepted: January 14, 2019
Article in press: January 14, 2019
Published online: February 7, 2019
Processing time: 70 Days and 20.6 Hours
Peer-review started: November 22, 2018
First decision: December 12, 2018
Revised: December 20, 2018
Accepted: January 14, 2019
Article in press: January 14, 2019
Published online: February 7, 2019
Processing time: 70 Days and 20.6 Hours
Core Tip
Core tip: Functional gastrointestinal disorders are diverse clinical entities whose pathogenesis and phenotype are thought to stem from both genetic and environmental factors. Many reviews have attempted to summarize general pathogenetic mechanisms related to functional gastrointestinal disorders (FGIDs), but more specific knowledge is currently limited. Studies on the brain-gut axis peptide ghrelin have chiefly concentrated on its association with obesity and eating disorders. This review focuses on the possible role of ghrelin in FGID pathogenesis, in an attempt to elucidate the contribution of certain genetic alterations to the emergence of disease.